Search Articles
Showing 1-10 of 1719 article(s)
1. Genetics and Personalized Medicines in Respiratory Disease: How Good is the Evidence?
Ian P Hall
Respiratory Drug Delivery 2012 (2012), Vol 1, pp 1-10
2. CD23, ADAM10 and Fullerenes – New Targets to Block Allergic Asthma
Daniel H Conrad, Jamie L Sturgill
Respiratory Drug Delivery 2012 (2012), Vol 1, pp 11-20
3. Development of Pitrakinra: An Interleukin Receptor Antagonist to Treat Eosinophilic Asthma
Babatunde Otulana, Alexandra Bowden, Yu Ping Yen, Silvy Puthukkeril
Respiratory Drug Delivery 2012 (2012), Vol 1, pp 21-28
4. Mucus Clearance and Asthma Exacerbations: Mechanisms, Models, and Drug Effects
William D Bennett
Respiratory Drug Delivery 2012 (2012), Vol 1, pp 29-38
5. Interferon-γ and Idiopathic Pulmonary Fibrosis: Why Pulmonary Targeting May be an Answer
Gerald C Smaldone, Rany Condos
Respiratory Drug Delivery 2012 (2012), Vol 1, pp 39-50
6. The Challenges of Developing an Inhaled Cyclosporine Product for Lung Transplant Patients
Ralph W Niven, Wendy Verret, Howard Raff, Timothy E Corcoran, Stephen G Dilly
Respiratory Drug Delivery 2012 (2012), Vol 1, pp 51-60
7. Engineered Drug Targeting to the Lungs: Ensuring Growth and Deposition of Submicrometer Aerosols Through Device Design and Formulation
P. Worth Longest, Geng Tian, Yoen-Ju Son, Xiang Li, Michael Hindle
Respiratory Drug Delivery 2012 (2012), Vol 1, pp 61-72
8. Regional Distribution of Organic Cation Transporters in Human Lung Epithelial Cells: Possible Therapeutic Implications in Aerosol Therapy
Johanna J Salomon, Carsten Ehrhardt
Respiratory Drug Delivery 2012 (2012), Vol 1, pp 73-80
9. Improved Metrics for Peripherally Targeted Aerosol Drugs: The Case for Combined Imaging and New Clinical Measurements
Omar S Usmani
Respiratory Drug Delivery 2012 (2012), Vol 1, pp 81-88
10. Regional Lung Deposition: Can it be Controlled and Have an Impact on Safety and Efficacy?
Andrew R Clark, Michael S Hartman
Respiratory Drug Delivery 2012 (2012), Vol 1, pp 89-100
